Clinical Associate Professor Veronica Wiley is the Director of the NSW Newborn Screening Programme, Australia. She is a clinical scientist with over 40 years of experience in paediatric biochemistry having worked in departments of Paediatric Biochemistry, Biochemical Genetics and Newborn Screening. Her qualifications include a PhD in clinical biochemistry, a fellowship of the Human Genetics Society of Australasia and a fellowship of the Faculty of Science of the Royal College of Pathologists of Australasia in biochemical genetics.
She is interested in all aspects of screening, detection, diagnosis and monitoring of inborn errors using techniques including immunoassay, mass spectrometry, enzyme assays and various DNA variant analyses. She has an interest data collection and storage relevant to screening.
She is a member of various international, national, and state committees developing aspects of newborn bloodspot screening for NSW, for Australia and for international use. A/Prof Wiley is immediate past-President of the Australasian Society for Inborn Errors of Metabolism and a past-President of the International Society for Neonatal Screening.
She is committed to education and training – supervising students and providing lectures, workshops and hands on training both in NSW and overseas. She has been primary supervisor for 1 PhD student, 11 Masters students and one student for BScHons.
Her research interests include all aspects of newborn bloodspot screening with the most recent grant from Luminesce Alliance (Paediatrio): Newborn Screening Program Pilot for Spinal Muscular Atrophy and Primary Immunodeficiency in NSW and ACT. Wiley V, Farrar M, Alexander I, Wong M, Cowell C ($2 million) Aug 2018 – July 2020
She has over 50 publications in peer reviewed journals including:
- Fifty years of newborn screening. Wilcken B Wiley V. J Paediatr Child Health. 2015 Jan; 51(1):103-7
- The implementation of newborn screening for spinal muscular atrophy: the Australian experience. Kariyawasam DST, Russell JS, Wiley V, Alexander IE, Farrar MA. Genetics in Medicine. 22(3):557-565, 2020 03
- Evaluation of a two tier screening pathway for congenital adrenal hyperplasia in the New South Wales Newborn Screening Programme. Lai F, Srinivasan S, Wiley V. Int J Neonatal Screen 2020, 6,63
